The Journal of Medical Microbiology, Vol 48, Issue 9 825-832, Copyright © 1999 by Society for General Microbiology

JOURNAL ARTICLE

Lipopolysaccharide chemotypes of Burkholderia cepacia

E. Evans, I. R. Poxton and J. R. Govan
Department of Medical Microbiology, University of Edinburgh Medical School, Teviot Place.

Burkholderia cepacia is an important pathogen in patients with cystic fibrosis (CF) and much is now known of its epidemiology. In contrast, its virulence mechanisms are poorly understood. The lipopolysaccharide (LPS) of B. cepacia, a well-recognised virulence factor of other gram-negative bacteria, is known to be strongly endotoxic in vitro. The aim of this study was to observe if there were any links between the structure of B. cepacia LPS and virulence. This has been investigated by polyacrylamide gel electrophoresis and immunoblotting to define the chemotype and antigenic cross reactivity of B. cepacia LPS. Strains (16) belonging to different genomovars of the B. cepacia complex were selected to represent epidemic and non-epidemic clinical isolates and environmental strains. All strains belonging to genomovars I and II (the latter now renamed B. multivorans) had smooth LPS. However, isolates belonging to genomovar III, the group to which most of the epidemic CF isolates belong - including the highly transmissible strain (ET 12) which has been found in both the UK and North America - were of either rough or smooth LPS chemotype. In this study, B. cepacia J2315 represents the ET 12 lineage, and has a rough chemotype. Rabbit antiserum raised to strain J2315 revealed that the LPS core of this strain was antigenically related to some but not all other genomovar III strains, but it also cross-reacted strongly with all B. multivorans (genomovar II) and most genomovar I strains. Intra-strain phenotypic variation was demonstrated between bacteria grown in broth or on solid agar with a concomitant variation in antigenic cross reactivity. There was no clear evidence to associate any particular LPS phenotype with epidemic or non-epidemic strains, but changes in phenotype in vitro may provide clues to the survival and adaptability of B. cepacia in hostile environments and possibly to its ability to produce an inflammatory response in vivo.

This article has been cited by other articles:

				A. De Soyza, C. D. Ellis, C. M. A. Khan, P. A. Corris, and R. D. de Hormaeche Burkholderia cenocepacia Lipopolysaccharide, Lipid A, and Proinflammatory Activity Am. J. Respir. Crit. Care Med., July 1, 2004; 170(1): 70 - 77. [Abstract] [Full Text] [PDF]

				A. D. Vinion-Dubiel and J. B. Goldberg Review: Lipopolysaccharide of Burkholderia cepacia complex Innate Immunity, August 1, 2003; 9(4): 201 - 213. [Abstract] [PDF]

				C A. Hart and C. Winstanley Persistent and aggressive bacteria in the lungs of cystic fibrosis children Br. Med. Bull., March 1, 2002; 61(1): 81 - 96. [Abstract] [Full Text] [PDF]

				E. Berriatua, I. Ziluaga, C. Miguel-Virto, P. Uribarren, R. Juste, S. Laevens, P. Vandamme, and J. R. W. Govan Outbreak of Subclinical Mastitis in a Flock of Dairy Sheep Associated with Burkholderia cepacia Complex Infection J. Clin. Microbiol., March 1, 2001; 39(3): 990 - 994. [Abstract] [Full Text]

				S. Brisse, C. M. Verduin, D. Milatovic, A. Fluit, J. Verhoef, S. Laevens, P. Vandamme, B. Tümmler, H. A. Verbrugh, and A. van Belkum Distinguishing Species of the Burkholderia cepacia Complex and Burkholderia gladioli by Automated Ribotyping J. Clin. Microbiol., May 1, 2000; 38(5): 1876 - 1884. [Abstract] [Full Text]